These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30175219)

  • 1. Pemphigoid gestationis and intravenous immunoglobulin therapy.
    Yang A; Uhlenhake E; Murrell DF
    Int J Womens Dermatol; 2018 Sep; 4(3):166-169. PubMed ID: 30175219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemphigoid gestationis: clinical and laboratory evaluation.
    Cobo MF; Santi CG; Maruta CW; Aoki V
    Clinics (Sao Paulo); 2009; 64(11):1043-7. PubMed ID: 19936176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis.
    Giudice GJ; Wilske KC; Anhalt GJ; Fairley JA; Taylor AF; Emery DJ; Hoffman RG; Diaz LA
    J Invest Dermatol; 1994 Jun; 102(6):878-81. PubMed ID: 7516396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspicion of pulmonary embolism during treatment of pemphigoid gestationis.
    Podolec-Rubiś M; Wołek M; Brzewski P; Wojas-Pelc A
    Postepy Dermatol Alergol; 2013 Feb; 30(1):59-61. PubMed ID: 24278048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen.
    Matsumura K; Amagai M; Nishikawa T; Hashimoto T
    Arch Dermatol Res; 1996 Aug; 288(9):507-9. PubMed ID: 8874743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in Japan.
    Ujiie H; Arakawa M; Aoyama Y
    J Dermatol Sci; 2023 Jan; 109(1):22-29. PubMed ID: 36697305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
    Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
    Front Immunol; 2022; 13():874108. PubMed ID: 35514989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
    Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J
    Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigoid gestationis: treatment with immunoapheresis.
    Wöhrl S; Geusau A; Karlhofer F; Derfler K; Stingl G; Zillikens D
    J Dtsch Dermatol Ges; 2003 Feb; 1(2):126-30. PubMed ID: 16285180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis.
    Nguyen T; Alraqum E; Razzaque Ahmed A
    Int Immunopharmacol; 2015 May; 26(1):1-3. PubMed ID: 25765353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Disease Outcome Measures in Bullous Pemphigoid on Standard-Of-Care Therapies.
    Cole EF; DeGrazia T; Sun Y; Liu Y; Feldman RJ
    JID Innov; 2021 Dec; 1(4):100050. PubMed ID: 34909747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of pemphigoid gestationis to bullous pemphigoid--two refractory cases highlighting this association.
    Jenkins RE; Jones SA; Black MM
    Br J Dermatol; 1996 Oct; 135(4):595-8. PubMed ID: 8915153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
    Liu Z; Diaz LA; Troy JL; Taylor AF; Emery DJ; Fairley JA; Giudice GJ
    J Clin Invest; 1993 Nov; 92(5):2480-8. PubMed ID: 7693763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis of bullous skin lesions in neonates: pemphigoid gestationis].
    König C; Wirbelauer J; Zillikens D; Speer CP
    Z Geburtshilfe Neonatol; 2004 Dec; 208(6):236-8. PubMed ID: 15647988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic herpes gestationis and antiphospholipid antibody syndrome successfully treated with cyclophosphamide.
    Castle SP; Mather-Mondrey M; Bennion S; David-Bajar K; Huff C
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):333-6. PubMed ID: 8655721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes gestationis (Pemphigoid gestationis).
    Al-Fouzan AW; Galadari I; Oumeish I; Oumeish OY
    Clin Dermatol; 2006; 24(2):109-12. PubMed ID: 16487884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Autoimmune Bullous Diseases During Pregnancy and Lactation: A Review Focusing on Pemphigus and Pemphigoid Gestationis.
    Genovese G; Derlino F; Berti E; Marzano AV
    Front Pharmacol; 2020; 11():583354. PubMed ID: 33117178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes gestationis.
    Morrison LH; Anhalt GJ
    J Autoimmun; 1991 Feb; 4(1):37-45. PubMed ID: 2031662
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.